Arkolith/Insider Trading/ATYR/Form 4

Schimmel Paul

DirectoraTYR PHARMA INC (ATYR) · full profile →Form 4 · filed Jul 24, 2024
Net Buying
Open-Market Buys
$184K
Open-Market Sells
$0
Net Open-Market Flow
$184K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2024Buy(P)52K$1.93$101K413K
Jul 23, 2024Buy(P)7K$1.82$12K361K
Jul 22, 2024Buy(P)41K$1.74$71K354K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-086159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML